These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 15219643)

  • 21. Behavioral and psychological symptoms and the progression of dementia of the Alzheimer type in nursing home residents.
    Bidzan L; Pachalska M; Grochmal-Bach B; Bidzan M; Jastrzebowska G
    Med Sci Monit; 2008 Nov; 14(11):CR559-67. PubMed ID: 18971872
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Atorvastatin/Donepezil in Alzheimer's Disease Study (LEADe): design and baseline characteristics.
    Jones RW; Kivipelto M; Feldman H; Sparks L; Doody R; Waters DD; Hey-Hadavi J; Breazna A; Schindler RJ; Ramos H;
    Alzheimers Dement; 2008 Mar; 4(2):145-53. PubMed ID: 18631958
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical experience with risperidone in the treatment of behavioral and psychological symptoms of dementia.
    Onor ML; Saina M; Trevisiol M; Cristante T; Aguglia E
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):205-9. PubMed ID: 17020789
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The dopaminergic neurotransmitter system is associated with aggression and agitation in frontotemporal dementia.
    Engelborghs S; Vloeberghs E; Le Bastard N; Van Buggenhout M; Mariën P; Somers N; Nagels G; Pickut BA; De Deyn PP
    Neurochem Int; 2008 May; 52(6):1052-60. PubMed ID: 18093695
    [TBL] [Abstract][Full Text] [Related]  

  • 25. AMPA potentiator treatment of cognitive deficits in Alzheimer disease.
    Chappell AS; Gonzales C; Williams J; Witte MM; Mohs RC; Sperling R
    Neurology; 2007 Mar; 68(13):1008-12. PubMed ID: 17389305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aggressive and impulsive behaviors in Frontotemporal dementia and Alzheimer's disease.
    Grochmal-Bach B; Bidzan L; Pachalska M; Bidzan M; Łukaszewska B; Pufal A
    Med Sci Monit; 2009 May; 15(5):CR248-54. PubMed ID: 19396041
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of age on response to rivastigmine or donepezil in patients with Alzheimer's disease.
    Bullock R; Bergman H; Touchon J; Gambina G; He Y; Nagel J; Lane R
    Curr Med Res Opin; 2006 Mar; 22(3):483-94. PubMed ID: 16574032
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Twenty-four hour growth hormone secretion in patients with panic disorder.
    Abelson JL; Curtis GC; Uhde TW
    Psychoneuroendocrinology; 2005 Jan; 30(1):72-9. PubMed ID: 15358444
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clonidine challenge in childhood anxiety disorder.
    Sallee FR; Richman H; Sethuraman G; Dougherty D; Sine L; Altman-Hamamdzic S
    J Am Acad Child Adolesc Psychiatry; 1998 Jun; 37(6):655-62. PubMed ID: 9628086
    [TBL] [Abstract][Full Text] [Related]  

  • 30. AVP- and OT-neurophysins response to apomorphine and clonidine in major depression.
    Scantamburlo G; Hansenne M; Fuchs S; Pitchot W; Pinto E; Reggers J; Ansseau M; Legros JJ
    Psychoneuroendocrinology; 2005 Oct; 30(9):839-45. PubMed ID: 15964147
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Central serotonergic activity is related to the aggressive behaviors of Alzheimer's disease.
    Lanctôt KL; Herrmann N; Eryavec G; van Reekum R; Reed K; Naranjo CA
    Neuropsychopharmacology; 2002 Oct; 27(4):646-54. PubMed ID: 12377401
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Noradrenergic function in pathological gambling: blunted growth hormone response to clonidine.
    Pallanti S; Bernardi S; Allen A; Chaplin W; Watner D; DeCaria CM; Hollander E
    J Psychopharmacol; 2010 Jun; 24(6):847-53. PubMed ID: 19028836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma levels of neuropeptides in Alzheimer's disease.
    Proto C; Romualdi D; Cento RM; Spada RS; Di Mento G; Ferri R; Lanzone A
    Gynecol Endocrinol; 2006 Apr; 22(4):213-8. PubMed ID: 16723308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuroendocrine correlates of antisocial personality disorder in abstinent heroin-dependent subjects.
    Gerra G; Zaimovic A; Moi G; Bussandri M; Delsignore R; Caccavari R; Brambilla F
    Addict Biol; 2003 Mar; 8(1):23-32. PubMed ID: 12745412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of behavioral and psychological symptoms in early-onset and late-onset Alzheimer's disease.
    Toyota Y; Ikeda M; Shinagawa S; Matsumoto T; Matsumoto N; Hokoishi K; Fukuhara R; Ishikawa T; Mori T; Adachi H; Komori K; Tanabe H
    Int J Geriatr Psychiatry; 2007 Sep; 22(9):896-901. PubMed ID: 17343292
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amisulpride in the treatment of behavioural disturbances among patients with moderate to severe Alzheimer's disease.
    Mauri M; Mancioli A; Rebecchi V; Corbetta S; Colombo C; Bono G
    Acta Neurol Scand; 2006 Aug; 114(2):97-101. PubMed ID: 16867031
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Validity and reliability of the Japanese Version of the Neuropsychiatric Inventory-Nursing Home Version (NPI-NH)].
    Shigenobu K; Hirono N; Tabushi K; Ikeda M
    Brain Nerve; 2008 Dec; 60(12):1463-9. PubMed ID: 19110758
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuropsychiatric symptoms of dementia: cross-sectional analysis from a prospective, longitudinal Belgian study.
    Engelborghs S; Maertens K; Nagels G; Vloeberghs E; Mariën P; Symons A; Ketels V; Estercam S; Somers N; De Deyn PP
    Int J Geriatr Psychiatry; 2005 Nov; 20(11):1028-37. PubMed ID: 16250064
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Age-related differences in growth hormone (GH) regulation during strenuous exercise.
    de Vries WR; Lambers M; van Zanten DP; Osman-Dualeh M; Maitimu I; Koppeschaar HP
    Horm Metab Res; 2004 Jul; 36(7):501-5. PubMed ID: 15305235
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anosognosia in Alzheimer's disease: association with patient characteristics, psychiatric symptoms and cognitive deficits.
    Kashiwa Y; Kitabayashi Y; Narumoto J; Nakamura K; Ueda H; Fukui K
    Psychiatry Clin Neurosci; 2005 Dec; 59(6):697-704. PubMed ID: 16401246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.